PMN310 demonstrated greater selectivity for target toxic oligomers over monomers compared to other amyloid-beta-directed antibodies

Greater selectivity of PMN310 for toxic oligomers indicates a potentially differentiated profile and supports further development

“In a joint press statement today, the Government of the Federal Democratic Republic of Ethiopia and the Kingdom of the Netherlands, along with their partners, endorsed an innovative initiative to implement Water Management through a fully digital approach. This groundbreaking endeavor has the potential to significantly improve the water quality, facilitate direct access, and increase the availability of water volumes for approximately 10 million individuals residing the metropolitan area of Addis Ababa”.

[PRESSWIRE] Londres - Le 03.03.23 -- Selon une NOUVELLE analyse publiée aujourd'hui par le groupe de recherche d'experts World Action on Salt, Sugar & Health (WASSH) et soutenue par l'ONG d'investissement responsable ShareAction, quatre des plus grands fabricants d'aliments au monde sont trop dépendants des ventes d'aliments malsains, malgré qu’ils prétendent améliorer les qualités nutritionnelles de leurs aliments.

[PRESSWIRE] Londres – 03.03.23 – Cuatro de los fabricantes de comida más importantes del mundo dependen demasiado en comida no saludable a pesar de que afirman estar trabajando en mejorar los valores de sus productos – Esto se basa en un nuevo análisis publicado hoy por un grupo experto de investigación en estos temas, World Action on Salt, Sugar & Health (WASSH) y apoyado por la ONG de inversión responsable, ShareAction. 

[PRESSWIRE] London – 03.03.23 -- Four of the world’s biggest food manufacturers are over reliant on the sales of unhealthy food despite each claiming to be active in improving the healthfulness of their products – that’s according to NEW analysis published today by expert research group, World Action on Salt, Sugar & Health (WASSH) and supported by responsible investment NGO, ShareAction.

[PRESSWIRE] Nairobi - November 9, 2022 -- The Digital Innovations and Diagnostics for Infectious Diseases in Africa (Didida) had its official kick-off at the Strathmore University. Didida is an ambitious project to develop reliable, low-cost, mobile phone-connected tests to help detect multiple infectious diseases and non-communicable diseases (NCD) at once in sub-Saharan Africa. Didida also plans to invest in digital health infrastructure and train a new generation of African experts to meet the health needs of the continent.

[PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Massachusetts – June 22, 2022 - ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the “Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, is pleased to announce that it has entered into debenture amendments with seven (7) creditors to settle an aggregate of US$7,000,000 of indebtedness via the issuance of 70,000,000 Series 1 Preferred Shares ("Series 1 Shares") of the Company at US$0.10 per share.

[PRESSWIRE] LUBBOCK, TX -- April 19, 2022 – NemaLife Inc., a DEA-registered and innovation-driven techbio company, has partnered with the research group led by Professor David E. Olson at the University of California, Davis to characterize the in vivo effects of several of their novel psychoplastogens.

Joint solutions leverage the new PassPro Wallet pass platform to deliver more interoperable and automated access and healthcare solutions

• Rapid molecular PCR-like accurate saliva-based test delivers 95% sensitivity and 98% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants
• Designed for point-of-care (POC) diagnosis, ease of use, rapid and cost-effective mass-screening
• A mobile-enabled, multiplex platform and connected solution enables efficient real-time reporting of results, track & trace, and surveillance